Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report

Published:2023-10-07 Issue:1 Volume:271 Page:584-588
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Zhang Zhouao,Wang Zhouyi,Du Xue,Huang Xiaoyu,Zhang Yong^ORCID

Funder

The Open Project of Key Laboratory of Colleges and Universities in Jiangsu Province

Science and Technology Development Fund of Afliated Hospital of Xuzhou Medical University

Medical research project of Jiangsu Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-023-12036-y.pdf

Reference15 articles.

1. Chen J, Tian D-C, Zhang C, Li Z, Zhai Y et al (2020) Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Reg Health West Pac 5:100063. https://doi.org/10.1016/j.lanwpc.2020.100063

2. Damato V, Spagni G, Monte G, Woodhall M, Jacobson L et al (2022) Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2022-329284

3. Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM et al (2019) Myasthenia gravis. Nat Rev Dis Primers 5:30. https://doi.org/10.1038/s41572-019-0079-y

4. Mantegazza R, Antozzi C (2018) When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther Adv Neurol Disord 11:1756285617749134. https://doi.org/10.1177/1756285617749134

5. Gomez-Figueroa E, Garcia-Trejo S, Bazan-Rodriguez L, Cervantes-Uribe R, Chac-Lezama G et al (2020) Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis. J Neurol 267:674–678. https://doi.org/10.1007/s00415-019-09622-4

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directional Texture Editing for 3D Models;Computer Graphics Forum;2024-09-02

2. IntrinsicDiffusion: Joint Intrinsic Layers from Latent Diffusion Models;Special Interest Group on Computer Graphics and Interactive Techniques Conference Conference Papers '24;2024-07-13

3. MVD^2: Efficient Multiview 3D Reconstruction for Multiview Diffusion;Special Interest Group on Computer Graphics and Interactive Techniques Conference Conference Papers '24;2024-07-13

4. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China;Neuropsychiatric Disease and Treatment;2024-03

5. Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study;Therapeutic Advances in Neurological Disorders;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3